GKB Ophthalmics Ltd. Corporate Filings & Announcements

Latest corporate announcements and filings from GKB Ophthalmics Ltd. on BSE

Search Inside the pdf :

GKB Ophthalmics Ltd.

09 Apr 2025, 04:55PM

62.43

-2.45%

Company Update

GKB Ophthalmics Ltd - 533212 - Announcement under Regulation 30 (LODR)-Credit Rating

BSE India

Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations , 2015 , we hereby inform that CRISIL Rating Limited ("CRISIL Ratings") has reaffirmed the credit ratings for the bank -based facilities of the Company , vide their letter dated April 09, 2025. A copy of the Rating Rationale issued by CRISIL is enclosed. We request you to take the above information on record.

pdf

GKB Ophthalmics Ltd.

08 Apr 2025, 04:14PM

62.43

-2.45%

Company Update

GKB Ophthalmics Ltd - 533212 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

BSE India

Please find herewith Certificate under Regulation 74(5) of SEBI ( Depositories and Participants) Regulations, 2018 , for the quarter ended March 31, 2025 Kindly acknowledge the receipt of the same.

pdf

GKB Ophthalmics Ltd.

02 Apr 2025

62.43

-2.45%

Company Update

GKB Ophthalmics Ltd - 533212 - Disclosure Under Regulations 31 (4) Of SEBI (Substantial Acquisition Of …

BSE India

Please find enclosed herewith the disclosure under Regulation 31 (4) of Securities and exchange Board of India (Substantial Acquisition of Shares and Takeover) Regulation 2011 for the financial year ended on March 31, 2025, received from Mr. Krishna Gopal Gupta (K.G. Gupta), Promoter of the Company on behalf of Promoter and Promoter group of the Company. We request you to please take the above information on record.

pdf

GKB Ophthalmics Ltd.

31 Mar 2025

62.43

-2.45%

Company Update

GKB Ophthalmics Ltd - 533212 - Intimation Under Regulation 30 Of SEBI( Listing Obligations And Disclosure …

BSE India

In compliance with Regulation 30 read with Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulation, 2015, this is to inform you that the Board of Directors of the Company by way of resolution passed by circulation today i.e. March 31, 2025, has, inter-alia, considered wand approved the following: 1. The Board members took note of the retirement of Mrs. Shashi Katreddi (DIN: 07139250) as an Independent Director Non- Executive Director of the Company with effect from close of business hours on March 31, 2025, due to the completion of her tenure. 2.Further, the Board of Directors of the Company has approved the re-constitution of the Audit Committee, Nomination and Remuneration Committee and Stakeholders'' Relationship Committee with effect from April 01, 2025. We request you to kindly take the above information on record.

pdf

GKB Ophthalmics Ltd.

31 Mar 2025

62.43

-2.45%

Company Update

GKB Ophthalmics Ltd - 533212 - Announcement under Regulation 30 (LODR)-Code of Conduct under SEBI (PIT) …

BSE India

Pursuant to provisions of Regulation 7(2) read with Regulation 6(2) of SEBI (Prohibition of Insider Trading) Regulations, 2015 (PIT Regulations 2015), intimation be and is hereby given that Krishna Gopal Gupta & Sons (HUF), has purchased 210 equity shares aggregating of Rs. 17,705.36 /- from 25.02.2025 to 25.02.2025, on market , which is not exceeding the threshold limit as prescribed under Regulation 7(2) of PIT Regulation ,2015. However, as a good Corporate Governance measure, the disclosure required under Regulation 7(2) read with Regulation 6(2) of PIT Regulation ,2015, is enclosed herewith along with the copy of disclosure received from Krishna Gopal Gupta & Sons-HUF . Please acknowledge and take the same on record.

pdf

GKB Ophthalmics Ltd.

29 Mar 2025

62.43

-2.45%

SAST

GKB Ophthalmics Ltd - 533212 - Closure of Trading Window

BSE India

Pursuant to SEBI (Prohibition of Insider Trading) Regulations 2015, as amended from time to time , the "Trading Window" for dealing/trading in the shares of the Company shall remain closed from April 01, 2025, till the completion of 48 hours after the declaration of the financial results of the Company for the quarter and financial year ended March 31, 2025. Accordingly, all the Promoters, Directors and Designated Persons of the Company and their immediate relatives are being intimated to not to enter into any transaction involving trading in shares of the Company, during the period of closure of Trading window. Further, the date of Board Meeting at which the said results will be considered, shall be intimated in due course of time.

pdf

GKB Ophthalmics Ltd.

27 Mar 2025

62.43

-2.45%

Company Update

GKB Ophthalmics Ltd - 533212 - Outcome Of Independent Directors'' Meeting Held On March 27, 2025.

BSE India

A separate meeting of the Independent directors of the Company for the year 2024-25, was held, pursuant to Regulation 25(3) of SEBI(Listing Obligations and Disclosure Requirements) Regulations, 2015 and section 149(8) of the Companies Act, 2013, read with Schedule IV (VII). The independent Director in their meeting held today: 1. Reviewed the performance of Non- Independent Directors and the Board as a whole. 2. Reviewed the performance of the Chairperson of the company, taking into account the views of the Executive and Non- Executive Directors. 3. Assessed the quality , quantity and timeliness of the flow of information between the company''s management and the Board. The Independent Directors'' Meeting started at 3:00 P.M 3: 34 P.M., on the same day.

pdf

GKB Ophthalmics Ltd.

18 Mar 2025

62.43

-2.45%

Company Update

GKB Ophthalmics Ltd - 533212 - Notice Of The Independent Directors'' Meeting

BSE India

Notice is hereby given that pursuant to Regulation 25 (3 and 4) of SEBI (Listing Obligations and Disclosure Requirements) Regulation 2015 and Schedule IV, clause VII of the Companies Acts , 2013, a separate meeting of the Independent Directors of GKB Ophthalmics Limited, will be held on Thursday, March 27, 2025, at the Registered office of the Company, interalia , to transact the following business: 1. To review the performance of the Non- Independent Directors and the Board of Directors as a whole. 2. To review the performance of the Chairman of the Company taking into account the views of the Executive Director and Non - Executive Directors. 3. To assess the quality, quantity and timeliness of flow of information between the Company Management and the Board that is necessary for the Board to effectively and reasonably perform their duties. 4. Any other matter with the permission of the Chair. Kindly take the information on record.

pdf

GKB Ophthalmics Ltd.

19 Feb 2025

62.43

-2.45%

Company Update

GKB OPHTHALMICS LTD. - 533212 - Announcement under Regulation 30 (LODR)-Newspaper Publication

BSE India

Please find attached copies of newspaper cuttings of the extract of Statement of Unaudited Standalone and Consolidated Financial Results for the quarter and nine months ended December 31, 2024, published in The Financial Express(Mumbai Edition) and on Pudhari (Marathi) dated February 15, 2025. Please acknowledge receipt.

pdf

GKB Ophthalmics Ltd.

13 Feb 2025

62.43

-2.45%

Corp. Note

GKB OPHTHALMICS LTD. - 533212 - Integrated Filing (Financial)

BSE India

Pursuant to SEBI Circular No. SEBI/HO/CFD/CFD-PoD-2/CIR/P/2024/185 dated December 31, 2024, read with BSE circular no. 20250102-4 dated January 02, 2025, please find enclosed herewith Integrated filing (Financial) of the Company for the quarter and nine months ended December 31, 2024. The above information will also be made available on the website of the Company at www.gkb.net. Kindly take the above information on record.

pdf

No results found

Is GKB Ophthalmics Ltd. worth buying?

12 Votes:

Buy 66.67%

Sell 33.33%